The HESI Cardiac Safety Committee will convene their annual business meeting on 28 February and 1 March 2022. The mission of the HESI Cardiac Safety Committee is to improve public health by reducing unanticipated cardiovascular-related adverse effects from drugs or chemicals, and to develop innovative approaches to support early detection and prediction as well as improved understanding of cardiovascular toxicology and pathobiology.
The meeting will feature updates from each of the main Committee Working Groups as well as a keynote speaker on emerging issues in the field of cardiovascular safety assessments. Participants will also have an opportunity to engage in discussions around current and potential future projects.
Learn more about the Cardiac Safety Committee by visiting their webpage or contact Dr. E’Lissa Flores and Ms. Jennifer Pierson.
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.